These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 13789398)

  • 1. [Behavior of the fibrinolytic activity after a single heparin load in atherosclerosis].
    JANIAKOWA A
    Pol Arch Med Wewn; 1960; 30():987-9. PubMed ID: 13789398
    [No Abstract]   [Full Text] [Related]  

  • 2. [HEPARIN, LIPOPROTEIN LIPASE AND BLOOD FIBRINOLYTIC ACTIVITY IN PATIENTS WITH ATHEROSCLEROSIS DURING IODINE PREPARATION TREATMENT].
    DZIZINSKII AA
    Ter Arkh; 1964 Aug; 36():58-62. PubMed ID: 14251670
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of prolonged treatment with heparin and dicoumarin derivatives on blood coagulability in atherosclerosis].
    JANIAKOWA A
    Pol Arch Med Wewn; 1960; 30():984-7. PubMed ID: 13789399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arteriosclerosis and heparin].
    GUTIERREZ-VALLEJO F
    Angiologia; 1962; 14():239-43. PubMed ID: 13903178
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of fibrinolytic activity of the plasma in various stages of atherosclerosis].
    SZCZEKLIK E; JANIAKOWA A; POTOCZEK S
    Pol Arch Med Wewn; 1960; 30():969-72. PubMed ID: 13774505
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical, biological, electroencephalographic and electromyographic changes in arteriosclerosis patients subjected prolonged heparin therapy].
    DE GREGORIO G; SERRA C; LOGOLUSO R; LAGANARA D
    Boll Soc Ital Biol Sper; 1962 Jul; 38():601-2. PubMed ID: 13884211
    [No Abstract]   [Full Text] [Related]  

  • 7. [ON CERTAIN INDICES OF HEPARIN METABOLISM AND FIBRINOLYTIC ACTIVITY OF THE BLOOD IN PATIENTS WITH CEREBRAL ATHEROSCLEROSIS WITH PSYCHIC DISORDERS].
    TROPPER MS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():275-80. PubMed ID: 14140455
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer concepts in antherosclerosis: sublingual heparin.
    LOEWE L; HALPERN A
    Angiology; 1961 Apr; 12():117-8. PubMed ID: 13763130
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of nicotinic acid on the fibrinolytic activity of the blood in atherosclerosis].
    SHERSHEVSKII MG
    Kardiologiia; 1963; 3():64-8. PubMed ID: 13977201
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the clearing action of a heparin-trypsin compound].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1962 Jan; 38():1-2. PubMed ID: 13875919
    [No Abstract]   [Full Text] [Related]  

  • 11. [Fibrinolytic activity and anticoagulant drugs].
    BERKARDA B
    Turk Tip Cemiy Mecm; 1963 Mar; 29():135-8. PubMed ID: 13970828
    [No Abstract]   [Full Text] [Related]  

  • 12. [FIBRINOLYTIC ACTIVITY. ITS IMPORTANCE IN ATHEROSCLEROSIS].
    BROCHIER M
    Sem Hop; 1965 Jan; 41():230-1. PubMed ID: 14295388
    [No Abstract]   [Full Text] [Related]  

  • 13. EFFECT OF NICOTINIC ACID ON FIBRINOLYTIC ACTIVITY OF THE BLOOD IN ATHEROSCLEROSIS.
    SHERSHEVSKII MG
    Fed Proc Transl Suppl; 1963; 22():1154-6. PubMed ID: 14079323
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the fibrinolytic action of a heparin-trypsin compound].
    CAMERADA P; CONGIU M; LEO P
    Boll Soc Ital Biol Sper; 1962 Jan; 38():2-3. PubMed ID: 13875920
    [No Abstract]   [Full Text] [Related]  

  • 15. [FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT].
    STOICHITA M
    Med Interna (Bucur); 1964 Oct; 16():1163-72. PubMed ID: 14244194
    [No Abstract]   [Full Text] [Related]  

  • 16. Variation in fibrinolytic activity after acute myocardial infarction and after the administration of oral anticoagulant drugs and intravenous heparin.
    LACKNER H; MERSKEY C
    Br J Haematol; 1960 Oct; 6():402-13. PubMed ID: 13758090
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acetylcholine arterioclysis in atherosclerotic arteriopathy. Study of fibrinolytic activity].
    ALLORI L; ISIDORI A; PATRIGNANI S; PEREGO MA
    Minerva Cardioangiol; 1961 Nov; 9():694-6. PubMed ID: 13860635
    [No Abstract]   [Full Text] [Related]  

  • 18. [ENDOGENOUS FIBRINOLYTIC POTENTIAL AND ITS STIMULATION BY A POLYSACCHARIDE ESTER].
    HALSE D
    Hemostase; 1963; 3():149-64. PubMed ID: 14050812
    [No Abstract]   [Full Text] [Related]  

  • 19. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE
    Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of fibrinolytic therapy in certain venous and arterial diseases].
    VITTORI C; GUAGLIANO G; VITTORI F
    Minerva Chir; 1962 Apr; 17():339-44. PubMed ID: 13926304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.